Sunday, August 23, 2026

Moderna cashes in on mRNA cancer vaccine without publishing trial results

Science by press release: Moderna cashes in on mRNA cancer vaccine without publishing trial results

"These corporations have learned how to play the medical-scientific establishment like a Stradivarius," Johns Hopkins cardiology operations chief says after Moderna share price spikes. Its mRNA flu vaccine trial data are still hidden.

No comments: